Argentina’s Institute for Clinical Effectiveness and Health Policy
Argentina’s Institute for Clinical Effectiveness and Health Policy
Resolution 1447/2026 replaces the 2021 primary-care essential medicines list behind Argentina’s Remediar programme with a list focused on vascular disease, leaving other conditions to provincial procurement after a transition kit …
The head of Buenos Aires’ Institute for Clinical Effectiveness and Health Policy says a national agency should give Argentina a common evidence base, not centralize every decision, and that coverage …
You must be logged in to post a comment.